Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: For patients who have a ventricular tachyarrhythmic event, implantable cardioverter-defibrillators (ICDs) are a mainstay of therapy to prevent sudden death. However, ICD shocks are painful, can result in clinical depression, and do not offer complete protection against death from arrhythmia. We designed this randomized trial to examine whether prophylactic radiofrequency catheter ablation of arrhythmogenic ventricular tissue would reduce the incidence of ICD therapy. METHODS: Eligible patients with a history of a myocardial infarction underwent defibrillator implantation for spontaneous ventricular tachycardia or fibrillation. The patients did not receive antiarrhythmic drugs. Patients were randomly assigned to defibrillator implantation alone or defibrillator implantation with adjunctive catheter ablation (64 patients in each group). Ablation was performed with the use of a substrate-based approach in which the myocardial scar is mapped and ablated while the heart remains predominantly in sinus rhythm. The primary end point was survival free from any appropriate ICD therapy. RESULTS: The mortality rate 30 days after ablation was zero, and there were no significant changes in ventricular function or functional class during the mean (+/-SD) follow-up period of 22.5+/-5.5 months. Twenty-one patients assigned to defibrillator implantation alone (33%) and eight patients assigned to defibrillator implantation plus ablation (12%) received appropriate ICD therapy (antitachycardia pacing or shocks) (hazard ratio in the ablation group, 0.35; 95% confidence interval, 0.15 to 0.78, P=0.007). Among these patients, 20 in the control group (31%) and 6 in the ablation group (9%) received shocks (P=0.003). Mortality was not increased in the group assigned to ablation as compared with the control group (9% vs. 17%, P=0.29). CONCLUSIONS: In this randomized trial, prophylactic substrate-based catheter ablation reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death. (Current Controlled Trials number, ISRCTN62488166 [controlled-trials.com].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) trial, 30 which randomly assigned 128 ICD patients with a history of ventricular arrhythmia and myocardial infarction to ablation or usual care, arrhythmia recurrence was significantly decreased from 33% to 12% with ablation.”
From Managing with pacemakers and implantable cardioverter defibrillators (2013) · cites this paper as [30]
Citations
Cites
(1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,232
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Marchlinski, F. E., Callans, D. J., Gottlieb, C. D., & Zado, E. (2000) · Circulation · doi:10.1161/01.cir.101.11.1288 · Cited by 1,220
Moss, A. J., Greenberg, H., Case, R. B., Zareba, W., Hall, W. J., Brown, M. W., Daubert, J. P., McNitt, S., Andrews, M. L., & Elkin, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000150390.04704.b7 · Cited by 597
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422
Guiraudon, G., Fontaine, G., Frank, R., Escande, G., Etievent, P., & Cabrol, C. (1978) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)62923-2 · Cited by 404
Electrical storm in patients with transvenous implantable cardioverter-defibrillators
Credner, S. C., Klingenheben, T., Mauss, O., Sticherling, C., & Hohnloser, S. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00495-1 · Cited by 376
Arenal, A., Glez-Torrecilla, E., Ortiz, M., Villacastín, J., Fdez-Portales, J., Sousa, E., del Castillo, S., Perez de Isla, L., Jimenez, J., & Almendral, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02623-2 · Cited by 343
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
Goldberger, Z., & Lampert, R. (2006) · JAMA · doi:10.1001/jama.295.7.809 · Cited by 271
Research works printed but not linked: 1
- Stevenson WG, 2005, Curr Opin Cardiol, 20, 42
Cited by
Items 401–500 of 964
Assessing patients for catheter ablation during hospitalization for acute heart failure
Knight, B. P., & Jacobson, J. T. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9240-8 · Cited by 11
“Catheter ablation has been shown to decrease defibrillator therapies [25, 26].”
BackgroundDroogan, C., Patel, C., Yan, G.-X., & Kowey, P. R. (2011) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.12.003 · Cited by 10
Kotake, Y., Huang, K., Bennett, R. G., Silva, K. D., Bhaskaran, A., Kanawati, J., Turnbull, S., Zhou, J., Campbell, T. G., & Kumar, S. (2023) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-023-01483-2 · Cited by 10
Contemporary updates on ventricular arrhythmias: from mechanisms to management
Bhaskaran, A., Silva, K. D., & Kumar, S. (2022) · Internal Medicine Journal · doi:10.1111/imj.15976 · Cited by 13
Adverse Prognosis of Patients With Septal Substrate After VT Ablation Due to Electrical Storm
Mueller, J., Chakarov, I., Halbfaß, P., Nentwich, K., Ene, E., Berkovitz, A., Sonne, K., Barth, S., Waechter, C., Behnes, M., et al. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2023.01.012 · Cited by 10
Chrispin, J., & Tandri, H. S. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2023.04.007 · Cited by 10
Pratola, C., BALDO, E., Toselli, T., Notarstefano, P., Artale, P., & Ferrari, R. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02398.x · Cited by 10
Bradfield, J. S., Huang, W. A., Tung, R. H., Buch, E. F., Okhovat, J., Fujimura, O., Boyle, N. G., GORNBEIN, J. A., Ellenbogen, K. A., & Shivkumar, K. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.02.020 · Cited by 11
Ablation of ventricular arrhythmias
Sadek, M. M., & Marchlinski, F. E. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.07.002 · Cited by 10
“[19] Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al.”
BackgroundGüler, T. E., Yalın, K., Aksu, T., Gölcük, E., Sanli, S., Bilge, A. K., & Adalet, K. (2018) · Medicine · doi:10.1097/md.0000000000012955 · Cited by 10
Liu, G., Xu, X., Yi, Q., & Lv, T. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-020-00848-1 · Cited by 11
“In SMASH-VT, about 87% of patients had ICD implanted before ablation [18].”
BackgroundMethodInfluentialNoordman, A. B. P., Maass, A. H., Groenveld, H. F., Mulder, B. A., Rienstra, M., & Blaauw, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.708406 · Cited by 10
“However, results from previous studies among secondary prevention ICD recipients indicate that earlier prophylactic VT ablation around the time of ICD placement is associated with a reduction in the incidence of appropriate ICD therapy (32, 33).”
ResultSp, G., Kostyukevich, M. V., Laiovich, L. I., Mironov, N. Y., Миронова, Н. А., Utsumueva, M. D., Khusyainova, D. R., Шлевков, Н. Б., Bazarov, B. C., Азизов, В. А., et al. (2022) · Eurasian heart journal · doi:10.38109/2225-1685-2022-4-6-67 · Cited by 14
Potential Application of Pulsed Field Ablation in Ventricular Arrhythmias
Qiu, J., Dai, M., Bai, Y., & Chen, G. (2023) · Medicina · doi:10.3390/medicina59040723 · Cited by 10
“Some clinical studies have shown the superiority of RFA over conventional medical therapy in controlling recurrent VT [27,28]; however, the overall complexity of this procedure has precluded its widespread use, and the long-term outcome is not always favorable [29].”
BackgroundStanciulescu, L. A., & Vatasescu, R. G. (2024) · Biomedicines · doi:10.3390/biomedicines12020266 · Cited by 10
Anter, E., & Josephson, M. E. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00084-4 · Cited by 10
Self-citationChen, Y., Gomes, M., Garcia, J. V., Hunter, R. J., CHOW, A. W. C., Dhinoja, M., SCHILLING, R. J., LOWE, M. D., & Lambiase, P. D. (2020) · Open Heart · doi:10.1136/openhrt-2019-001155 · Cited by 10
Souček, F., Caluori, G., Lehár, F., Jež, J., Pešl, M., Wolf, J., Wojtaszczyk, A., Bělašková, S., & Stárek, Z. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14407 · Cited by 10
“These factors may contribute to the high reported rates of VT recurrence after UPA, spanning a range of 12% to 47%.(2,9) Bipolar ablation (BPA), alternatively, focuses RF energy between the closely placed distal electrodes of two ablation catheters (see Figure 1), maintaining a controlled, relatively high current dens…”
BackgroundThoppil, P. S., Rao, B. H., Jaishankar, S., & Narasimhan, C. (2008) · Europe PMC (PubMed Central) · Cited by 10
Cori, A. D., Pistelli, L., Parollo, M., Zaurino, N., Segreti, L., & Zucchelli, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175017 · Cited by 9
“At 23 months, 33% of the patients who did not undergo catheter ablation and 12% of the patients treated with catheter ablation experienced appropriated ICD shock (hazard ratio in the ablation group, 0.35; 95% confidence interval, 0.15 to 0.78; p = 0.007) [68].”
BackgroundInfluentialCatheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia
Nery, P. B., Wells, G. A., TANG, A. S. L., Parkash, R., Stevenson, W. G., Healey, J. S., Gula, L. J., Nair, G. M., Essebag, V., Rivard, L., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.09.1595 · Cited by 10
Shalganov, T. N., Stoyanov, M. K., & TRAYKOV, V. B. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1063147 · Cited by 9
“Eight randomized clinical trials satisfying the criteria were included in this review and meta-analysis–SMASH-VT (25), VTACH (26), VANISH (27), SMS (28), BERLIN VT (29), PARTITA (30), SURVIVE-VT (31), and PAUSE-SCD (32).”
BackgroundMethodInfluentialReddy, R. K., Howard, J. P., Ahmad, Y., Shun-Shin, M. J., Simader, F. A., Miyazawa, A. A., Saleh, K., Naraen, A., Samways, J., Katritsis, G., et al. (2023) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2023.07 · Cited by 10
“15,16,20,21 All five eligible trials reported 24-month follow-up for all-cause mortality, and therefore this time point formed the primary analysis.”
BackgroundSipko, J., Baranowski, B. J., Bhargava, M., Callahan, T. D., Dresing, T., Higuchi, K., Hussein, A. A., Kanj, M. H., Lee, J. Z., Martin, D. O., et al. (2024) · EP Europace · doi:10.1093/europace/euae185 · Cited by 9
Treatment of Ventricular Tachycardia in Patients with Heart Failure
Fong, M., Grazette, L. P., Cesario, D. A., Cao, M. K., & Saxon, L. A. (2011) · Current Cardiology Reports · doi:10.1007/s11886-011-0182-5 · Cited by 9
“Therapeutic catheter ablation and antiarrhythmic drugs play a necessary role as adjunctive therapy in such patients [ 14 ].”
BackgroundInfluentialNew strategies for ventricular tachycardia and ventricular fibrillation ablation
Hooks, D. A., Berte, B., Yamashita, S., Mahida, S., Sellal, J., Al-Jefairi, N., Frontera, A., Derval, N., Denis, A., Hocini, M., et al. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1009039 · Cited by 9
“In the multi-centre SMASHVT trial [7], 128 patients with ICD for spontaneous VT or VF were assigned to either prophylactic substrate-based ablation or standard medical therapy without anti-arrhythmic.”
MethodMüller, J., Chakarov, I., Halbfaß, P., Nentwich, K., Berkovitz, A., Sonne, K., Barth, S., Lehrmann, H., & Deneke, T. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02378-6 · Cited by 9
“In the past decades, catheter ablation of sustained VTs has become an important and effective treatment option to reduce VT recurrences and pro-long ICD shock-free survival [2, 3].”
Tereshchenko, L. G., Waks, J. W., TOMPKINS, C. M., Rogers, A. J., Ehdaie, A., Henrikson, C. A., Dalouk, K. A., Raitt, M. H., Kewalramani, S., Kattan, M. W., et al. (2024) · EP Europace · doi:10.1093/europace/euae127 · Cited by 10
Suzuki, A., Yoshida, A., Takei, A., Fukuzawa, K., Kiuchi, K., Takami, K., Itoh, M., Imamura, K., Fujiwara, R., Nakanishi, T., et al. (2015) · Journal of Arrhythmia · doi:10.1016/j.joa.2014.09.007 · Cited by 9
“Recent studies have reported the efficacy of prophylactic catheter ablation (PCA) before ICD implantation in patients with ventricular tachycardia (VT) and ischemic cardiomyopathy [4–6].”
BackgroundArrhythmias in the Coronary Care Unit
Badhwar, N., Kusumoto, F. M., & Goldschlager, N. (2011) · Journal of Intensive Care Medicine · doi:10.1177/0885066611402165 · Cited by 9
The role of pharmacotherapy in the prevention of sudden cardiac death in patients with heart failure
Weeks, P. A., Sieg, A. C., Gass, J. A., & Rajapreyar, I. N. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9546-7 · Cited by 9
Schupp, T., Behnes, M., Reiser, L., Bollow, A., Taton, G., Reichelt, T., Ellguth, D., Engelke, N., Ansari, U., El‐Battrawy, I., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.11.030 · Cited by 9
Intracardiac echocardiography use and outcomes after catheter ablation of ventricular tachycardia
Field, M. E., Goldstein, L. J., Lee, S. H., Kalsekar, I. D., COPLAN, P. M., Wong, C., Khanna, R., Gold, M. R., Reynolds, M. R., & Winterfield, J. R. (2020) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2019-0156 · Cited by 9
Self-citationChakarov, I., Mueller, J., Ene, E., Berkovitz, A., Sonne, K., Nentwich, K., Schupp, T., Behnes, M., & Deneke, T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144000 · Cited by 9
“Previous studies have not shown a relationship between VT recurrence and complete ablation success [10,12], while other authors reported that failure to achieve non-inducibility leads to adverse long-term outcome [16,18].”
BackgroundResultAnderson, R. D., Lee, G., Prabhu, M. A., Patrick, C. J., Trivic, I., Campbell, T. G., Chow, C. K., Kalman, J. M., & Kumar, S. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14143 · Cited by 9
Maan, A., Waseem, M., Carter, A., Vashishtha, K., Dhanjal, T., Koruth, J. S., & Heist, E. K. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf076 · Cited by 8
“One of the earlier RCTs, SMASH-VT was primarily conducted between 2000 and 2006 predominantly in the US, 14 while the subsequent RCTs such as the VTACH trial in 2010, 15 and more recent trials such as the SMS, 16 PARTITA 17 and BERLIN-VT 18 trials were conducted in the European Union.”
on behalf of the PAUSE-SCD investigators, Chen, M., Wu, S., Yao, Y., Jiang, J. D., Jiang, C., Xue, Y., Zhan, X., Hu, H., Fu, G., et al. (2019) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00535-w · Cited by 8
Tilz, R. R., Kück, K., Kääb, S., Wegscheider, K., Thiem, A., Wenzel, B., Willems, S., & Steven, D. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-022910 · Cited by 8
“However, no published trial so far showed significant reduction in mortality after catheter ablation, mainly due to the fact that studies focused on the ICD shock recurrence and were underpowered to reveal differences in mortality.(24)”
ResultInfluentialHongo, R. H. (2019) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2019.100603 · Cited by 8
Ventricular Tachycardia Ablation Endpoints
Santangeli, P., Higuchi, K., & Sroubek, J. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2023.12.009 · Cited by 8
Khan, U., Khlidj, Y., Ibrahim, A. A., Amin, A. M., Rakab, M. S., AlBarakat, M. M., Khan, M. H., Majeed, Z., Imran, M., Ali, J., et al. (2025) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2025.03.004 · Cited by 8
“Among the eight studies reviewed, six were categorized as having a low risk of bias regarding the five domains [6,8,15,16,18].”
Zaman, S. J., Sivagangabalan, G., CHIK, W. W. B., Stafford, W. J., Hayes, J., Denman, R. A., Young, G. D., Sanders, P., & Kovoor, P. (2014) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-014-9941-8 · Cited by 8
Ventricular Tachycardia in Coronary Artery Disease
Haqqani, H. M., & Callans, D. J. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2014.05.003 · Cited by 8
Özcan, F., Topaloğlu, S., Çay, S., Canpolat, U., Özeke, Ö., Turak, O., Çetin, E. H. Ö., & Aras, D. (2015) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2015.6095 · Cited by 8
“These studies reported delayed recurrence of VT and reduced incidence of ICD therapy, in patients who underwent CA (3, 6).”
BackgroundOgunbayo, G. O., Charnigo, R. J., Darrat, Y., Shah, J. S., Patel, R., Suffredini, J. M., Wilson, W., Parrott, K., Kusterer, N., Biase, L. D., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.07.001 · Cited by 8
Kampaktsis, P. Ν., Doulamis, I. P., Tzani, A. I., & Cheung, J. W. (2020) · Heart Rhythm O2 · doi:10.1016/j.hroo.2020.08.001 · Cited by 10
Smoczyńska, A., Sprenkeler, D. J., Hernandez, A. A., Beekman, J. D. M., Bossu, A., Dunnink, A., Wijers, S. C., Stegemann, B., Meine, M., & Vos, M. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01005 · Cited by 8
Ablation of ventricular tachycardia in 2021
Bianchi, S., & Cauti, F. M. (2021) · European Heart Journal Supplements · doi:10.1093/eurheartj/suab082 · Cited by 8
Samuel, M., Rivard, L., Nault, I., Gula, L. J., Essebag, V., Parkash, R., Sterns, L. D., Khairy, P., & Sapp, J. L. (2021) · EP Europace · doi:10.1093/europace/euab298 · Cited by 8
Sánchez-Somonte, P., Dyrda, K., Nault, I., Rivard, L., & Verma, A. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.06.008 · Cited by 8
Enriquez, A. A., Sadek, M. M., Hanson, M. G., Yang, J., Matos, C. D., Neira, V., Marchlinski, F. E., Miranda‐Arboleda, A. F., Orellana-Cáceres, J.-J., Alviz, I., et al. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.03.011 · Cited by 8
Actualización en arritmias y electrofisiología cardiaca
Arenal, Á., Castel, M., López‐Gil, M., & Merino, J. L. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70042-9 · Cited by 8
Mizuno, H., Maccabelli, G., & Bella, P. E. D. (2012) · EP Europace · doi:10.1093/europace/eus209 · Cited by 8
For Whom the Bell Tolls: Refining Risk Assessment for Sudden Cardiac Death
Tonchev, I., Luria, D. M., Orenstein, D., Lotan, C., & Biton, Y. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1191-z · Cited by 9
Kitamura, Τ., Maury, P., Lam, A., Sacher, F., Khairy, P., Martin, R. I. R., Vlachos, K. G., Frontera, A., Takigawa, M., Nakatani, Y., et al. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006857 · Cited by 8
Halbfaß, P., Ludwig, D., Sonne, K., Nentwich, K., Ene, E., Berkovitz, A., Foldyna, B., Barth, S., Müller, J., Lehmkuhl, L., et al. (2021) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2021.10.002 · Cited by 8
Management of ventricular arrhythmias in heart failure: Current perspectives
Peichl, P., Rafaj, A., & Kautzner, J. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.08.007 · Cited by 8
Innovations in ventricular tachycardia ablation
Marashly, Q., Najjar, S. N., Hahn, J., Rector, G., Khawaja, M., & Chelu, M. G. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01311-z · Cited by 8
Kipp, R. T., Kalscheur, M. M., Sheehy, A. M., Bartels, C. M., Kind, A., & Powell, W. R. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027093 · Cited by 8
Nair, G. M., Healey, J. S., Gordon, E., Divakaramenon, S., & Morillo, C. A. (2011) · PubMed Central · Cited by 8
Catheter Ablation of Post-Infarct VT: Mechanisms, Strategies and Outcomes
Emami, M., Morton, J. B., Chan, K. H., & Roberts‐Thomson, K. C. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.10.003 · Cited by 8
Porta‐Sánchez, A., Ha, A. C. T., Wang, X., Almehmadi, F., Austin, P. C., Fischer, H. D., AlQubbany, A., Chemello, D., Chauhan, V. S., Downar, E., et al. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.10.011 · Cited by 8
Tebbenjohanns, J., Willems, S., Antz, M., Pfeiffer, D., Seidl, K., & Lewalter, T. (2008) · Der Kardiologe · doi:10.1007/s12181-008-0112-y · Cited by 12
Role of catheter ablation of ventricular tachycardia associated with structural heart disease
Ponti, R. D. (2011) · World Journal of Cardiology · doi:10.4330/wjc.v3.i11.339 · Cited by 8
Ablation after ICD Implantation — Bridging the Gap between Promise and Practice
Estes, N. A. M. (2007) · New England Journal of Medicine · doi:10.1056/nejme0706860 · Cited by 8
Zeppenfeld, K. (2012) · EP Europace · doi:10.1093/europace/eus030 · Cited by 8
Wang, X., Dennis, A. S., Hesselkilde, E. M., Saljic, A., Linz, B. M., Sattler, S. M., Williams, J., Tfelt‐Hansen, J., Jespersen, T., CHOW, A. W. C., et al. (2025) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztaf064 · Cited by 9
“14 The EnSite Precision ™ 3D cardiac mapping sys-tem (Abbott Medical, IL, USA) and the 16-electrode Advisor ™ HD Grid Sensor Enabled Mapping Catheter (Abbott Medical, IL, USA) were used to create 3D electro-anatomical maps.”
Raatikainen, P. M. J., Mäkynen, H., Hartikainen, J. E. K., Jensen‐Urstad, M., Konkola, L., Sandgaard, N. C. F., Lukáč, P., Johannessen, A. C., Jönsson, A., Schuster, P. M., et al. (2025) · EP Europace · doi:10.1093/europace/euaf236 · Cited by 7
“12,19 Nevertheless, even in the light of the most recent trials, 20–25 the optimal timing of RFCA in post-MI patients remains disputable and more information is needed to determine whether RFCA or AAD should be the first-line therapy after the first ICD shock in patient with no previous AAD therapy.”
The role of catheter ablation for ventricular tachycardia in patients with ischemic heart disease
El‐Damaty, A., & Sapp, J. L. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328341390b · Cited by 8
Sudden Death in Men Versus Women with Heart Failure
Martínez-Solano, J., & Martínez‐Sellés, M. (2023) · Current Heart Failure Reports · doi:10.1007/s11897-023-00596-z · Cited by 8
Catheter Ablation for Ventricular Tachycardias: Current Status and Future Perspectives
Kataoka, N., & Imamura, T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226805 · Cited by 7
Nesti, M., Lucà, F., Duncker, D., Sensi, F. D., Małaczyńska-Rajpold, K., Behar, J. M., Waldmann, V., Ammar, A. S., Mirizzi, G., Garcia, R., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196183 · Cited by 7
“In the SMASH VT study [33], OAC was continued for 4 to 6 weeks (providing that they had more than five CA lesions).”
BackgroundMethodGard, J. J., & Friedman, P. A. (2011) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2011.05.004 · Cited by 7
Jiménez, A., Kuk, R. S., Ahmad, G., Tian, J., Garcia, J. P., SALIARIS, A. P., Shorofksy, S., & Dickfeld, T. M. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.959247 · Cited by 7
Manuchehry, A., Agusala, K., Montevecchi, M., Kadish, A. H., & PASSMAN, R. S. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.03004.x · Cited by 8
Aneurysm-related ischemic ventricular tachycardia
Guo, J., Zheng, L., Wu, L., Ding, L., & Yao, Y. (2017) · Medicine · doi:10.1097/md.0000000000006442 · Cited by 7
Conquest of Ventricular Tachycardia: Insights Into Mechanisms, Innovations in Management
Shenasa, M., Miller, J. M., Callans, D. J., Almendral, J. M., Marchlinski, F. E., & Buxton, A. E. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005150 · Cited by 7
Tenma, T., Yokoshiki, H., Mitsuyama, H., Watanabe, M., Mizukami, K., Kamada, R., Takahashi, M., Sasaki, R., Maeno, M., Okamoto, K., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.02.063 · Cited by 8
“However, no randomized clinical trials have demonstrated that catheter ablation reduce the risk of death in patients receiving an ICD [29-32].”
BackgroundZhou, S., Horáček, B. M., Warren, J. W., AbdelWahab, A. M., & Sapp, J. L. (2018) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2018.07.022 · Cited by 7
Stoks, J., Hermans, B. J. M., Boukens, B. J., Holtackers, R. J., Gommers, S., Kaya, Y. S., Vernooy, K., Cluitmans, M. J. M., Volders, P. G. A., & ter Bekke, R. M. A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1112980 · Cited by 7
“Catheter ablation of arrhythmogenic substrate and triggers of ventricular tachycardia (VT) reduces arrhythmia burden and implantable cardioverter-defibrillator (ICD) shocks (1, 2) but recurrences [30–40% within 1–2 years (3, 4)], costs and complication rates remain high (5, 6).”
BackgroundMethodGender and race-related disparities in the management of ventricular arrhythmias
Yoder, M., Dils, A., Chakrabarti, A. K., Driesenga, S., Alaka, A. A., Ghannam, M., Bogun, F. M., & Liang, J. J. (2023) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2023.10.001 · Cited by 7
Death with an implantable cardioverter-defibrillator: a MADIT-II substudy
Chernomordik, F., Jøns, C., Klein, H., Kutyifa, V., Nof, E., Zaręba, W., Daubert, J. P., Greenberg, H., Glikson, M., Goldenberg, I., et al. (2019) · EP Europace · doi:10.1093/europace/euz263 · Cited by 7
The year in arrhythmias—2009: Part I
Olshansky, B., Delmar, M., & Tomaselli, G. F. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.12.011 · Cited by 7
Pulsed field ablation for ventricular tachycardia: are we there yet?
Biase, L. D., Merino, J. L., & Natale, A. (2025) · EP Europace · doi:10.1093/europace/euaf161 · Cited by 7
Dasa, O., Younis, A., Higuchi, K., Sroubek, J., Lee, J. Z., Chung, R., Nakhla, S., Hight, N., Varma, N., Hussein, A. A., et al. (2026) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2026.03.002 · Cited by 6
Electrophysiology Studies in Patients Undergoing ICD Implantation: Findings from the NCDR®
Cheng, A., Wang, Y., Berger, R. D., Calkins, H. G., Buxton, A. E., Curtis, J. P., & Lampert, R. J. (2012) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2012.03441.x · Cited by 6
Approach to Ablation of Unmappable Ventricular Arrhythmias
Fernández‐Armenta, J., Penela, D., Acosta, J., Andreu, D., & Berruezo, A. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.05.011 · Cited by 6
Fong, K. Y., Chan, Y. H., Wang, Y., Yeo, C., Lim, E. T. S., & Tan, V. H. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.12.004 · Cited by 7
Catheter Ablation for Ventricular Tachycardia After Myocardial Infarction
Reddy, R. K., Samways, J., Howard, J. P., Ahmad, Y., Shun-Shin, M. J., Saleh, K., Naraen, A., Kanagaratnam, P., Whinnett, Z. I., & Arnold, A. D. (2025) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2025.02.039 · Cited by 6
Średniawa, B., Kowalczyk, J. P., Lenarczyk, R., Kowalski, O., Sędkowska, A., Cebula, S., Musialik-Lydka, A., & Kalarus, Z. F. (2012) · PubMed · Cited by 6
Kim, J., Han, D., Sohn, C.-B., Kim, J., & Park, Y. H. (2012) · Korean Circulation Journal · doi:10.4070/kcj.2012.42.9.632 · Cited by 6
Methods and indications for ablation of ventricular tachycardia.
Letsas, Κ. P., Charalampous, C., Weber, R., Tsikrikas, S., Efremidis, M., Arentz, T., & Sideris, A. (2011) · PubMed · Cited by 7
Inappropriate ICD Shocks in Pediatric and Congenital Heart Disease Patients
Garnreiter, J. M. (2017) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2017.081104 · Cited by 6
“The SMASH-VT study found that the ablation of VT in adult patients post-myocardial infarction reduced the number of patients receiving appropriate ICD shocks from 33% to 12%, without increasing mortality.(50) The VTACH study found that prophylactic VT ablation in adult patients with coronary artery disease reduced app…”
MethodEnriquez, A. A., Briceno, D. F., Tapias, C., Shirai, Y., Muser, D., Liang, J. J., Hayashi, T., Santangeli, P., Frankel, D. S., Supple, G. E., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.02.016 · Cited by 6
Gender differences in patients with structural heart disease undergoing VT ablation
Darma, A., Bertagnolli, L., Torri, F., Lurz, J. A., König, S., Ueberham, L., Bollmann, A., Dagres, N., Hindricks, G., Dinov, B., et al. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15219 · Cited by 6
Amin, M., Farwati, M., Hilaire, E., Siontis, K. C., Madhavan, M., Kapa, S., Mulpuru, S. K., Deshmukh, A. J., Cha, Y., Friedman, P. A., et al. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15273 · Cited by 6
“Antiarrhythmic drugs (AADs) and radiofrequency catheter ablation (RFA) are frequently used to reduce the frequency of VT and shocks in patients with implantable cardioverter‐defibrillators (ICDs).(6) However, while VT in the setting of post‐MI LVA is not uncommonly encountered, there is a scarcity of data in the publi…”
BackgroundSciacca, V., Fink, T., Bergau, L., Imnadze, G., Hamriti, M. E., Guckel, D., BRAUN, M. U., Khalaph, M., Sommer, P., & Sohns, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092418 · Cited by 6
Biologic Pacemaker - Role of Gene and Cell Therapy in Cardiac Arrhythmias
Khafaji, H. (2011) · InTech eBooks · doi:10.5772/19604 · Cited by 6
“Using mapping to identify the border zone of an infarct in a canine model ablation were replaced with intramyocardially-administered gene therapy in preliminary studies and without destroying tissue - achieved a reduction in VT/VF incidence (Reddy et al 2007, Lau et al 2009).”
MethodShock Avoidance and the Newer Tachycardia Therapy Algorithms
Rajamani, K., Goldberg, A., & Wilkoff, B. L. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.01.002 · Cited by 6
Ablation of Ventricular Arrhythmia in Patients with Heart Failure
CHIK, W. W. B., & Marchlinski, F. E. (2015) · Heart Failure Clinics · doi:10.1016/j.hfc.2014.12.009 · Cited by 6
Metadata
- Authors
- Reddy, V. Y., Reynolds, M. R., Neuzil, P., Richardson, A. W., Taborsky, M., Jongnarangsin, K., Kralovec, S., Sediva, L., Ruskin, J. N., & Josephson, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-12-27
- Volume
- 357
- Issue
- 26
- Pages
- 2657-2665
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2390777
- OpenAlex
- W2139803224
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 39 · 2025: 42 · 2024: 47 · 2023: 43 · 2022: 53 · 2021: 45 · 2020: 54 · 2019: 62 · 2018: 53 · 2017: 63 · 2016: 40 · 2015: 59 · 2014: 46 · 2013: 56 · 2012: 48
- FWCI
- 33.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23 HL 68064, K23HL077171, K23HL068064)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- implantable cardioverter-defibrillator, ventricular tachyarrhythmia, myocardial infarction, sudden cardiac death, radiofrequency ablation, substrate-based ablation, myocardial scar, ICD shocks, secondary prevention
- MeSH terms
- Aged, Electric Countershock, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Ventricular Fibrillation, Multivariate Analysis, Death, Sudden, Cardiac, Catheter Ablation, Defibrillators, Implantable, Tachycardia, Ventricular, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.